DC23061 |
L-45 |
PCAF BRD inhibitor L-45 is a potent, selective, and cell-active PCAF bromodomain inhibitor with Ki of 47 nM in HTRF assays, >4,500-fold selectivity over BRD4. |
|
DC23651 |
PCARBTP |
PCARBTP is a derivative, potent, specific Kv1.3 channel inhibitor, reduces cell viability and efficiently kills B16F10 cancer cells at 1 uM. |
|
DC11169 |
PCC0104005 |
PCC0104005 (PCC-0104005) is a novel modulator of serotonin, dopamine, and noradrenaline receptors, including partial agonism at dopamine D2, D3, D4, serotonin 5-HT1A, and 5-HT2A receptors and antagonism at 5-HT2B, 5-HT6, and 5-HT7 receptors. |
|
DC10757 |
PCI-29732
Featured
|
PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay. |
|
DC8844 |
PCI-27483
Featured
|
PCI-27483 is a selective small molecule inhibitor of activated coagulation factor VII (FVIIa), which is in preclinical development as a novel anti-cancer agent. |
|
DC1106 |
PCI-32765 (Ibrutinib)
Featured
|
PCI-32765 (Ibrutinib) is a potent and highly selective Btk inhibitor with IC50 of 0.5 nM. |
|
DC12080 |
PCI-33380 |
PCI-33380 is an irreversible Bruton's Tyrosine Kinase (BTK) inhibitor (fluorescent probe). |
|
DC1109 |
PCI-34051
Featured
|
PCI-34051 is a potent and specific HDAC8 inhibitor with IC50 of 10 nM. |
|
DC10531 |
PCO371
Featured
|
PCO371 is a novel, orally active small molecule that acts as a full agonist of PTHR1. |
|
DC23759 |
PCSK9 modulator 10 |
PCSK9 modulator 10 is a highly potent, orally active PCSK9 modulator that inhibits PCSK9 production in HepG2 cells with IC50 of 0.036 nM. |
|
DC23758 |
PCSK9-IN-7l |
PCSK9-IN-7l is a potent, small molecule PCSK9 mRNA translation inhibitor with IC50 of 1.37 uM, shows limited bone marrow toxicity (IC50=27.1 uM).. |
|
DC7224 |
PD 123319
Featured
|
PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM. |
|
DC8283 |
PD 150606
Featured
|
PD 150606 is a selective, cell-permeable non-peptide calpain inhibitor (Ki values for ν and m-calpains are 0.21 and 0.37 μM respectively). |
|
DC8747 |
PD-151746
Featured
|
PD 151746 is a selective, cell-permeable calpain inhibitor with Ki of 0.26 μM for μ-Calpain, about 20-fold selectivity over m-calpain. |
|
DC8078 |
PD 153035(AG-1517)
Featured
|
PD 153035(AG-1517) is an ultra-potent inhibitor of epidermal growth factor receptor tyrosine kinase (EGFRK), with an IC50 of 25 pM. |
|
DC5100 |
PD 98059
Featured
|
PD 98059 is a selective inhibitor of MEK and blocker of MAPK |
|
DC9744 |
PD0166285
Featured
|
PD0166285 is a potent Wee1 and Chk1 inhibitor with activity at nanomolar concentrations.PD0166285 is a novel G2 checkpoint abrogator. |
|
DC1056 |
PD0325901 (Mirdametinib)
Featured
|
PD0325901 (PD325901) is selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM. |
|
DC9280 |
BMS-1 (PD1/PDL1 inhibitor 1)
Featured
|
PD-1/PD-L1 inhibitor 1 is a PD-1/PD-L1 interaction inhibitor,IC50 values: 0.006-0.10 μM,a useful immunomodulator compound. |
|
DC8381 |
PD-1/PD-L1 inhibitor 2(BMS-202)
Featured
|
PD-1/PD-L1 inhibitor 2 is reported to prevent the interaction of PD-L1 with PD-1 with an IC50 value of 18 nM,a useful compound immunomodulator compound. |
|
DC5021 |
PD153035 HCl (SU-5271, AG1517)
Featured
|
PD153035 is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM; little effect noted against PGDFR, FGFR, CSF-1, InsR and Src. |
|
DC7842 |
PD158780
Featured
|
PD158780 is a very potent inhibitor of EGFR with IC50 of 0.08 nM; pan-specific antagonist of ErbB receptor. |
|
DC21466 |
PD166285
Featured
|
PD166285 (PD 0166285) is a broad-spectrum receptor tyrosine kinase (RTK) inhibitor that inhibits PDGFR-β, EGFR, and FGFR1 and c-Src with IC50 of 7-85 nM. |
|
DC10068 |
PD166866
Featured
|
PD-166866 is a selective inhibitor of the FGF-1 receptor tyrosine kinase (FGFR1) with IC50 = 55 nM, and no effect on c-Src, PDGFR-b, EGFR or insulin receptor tyrosine kinases or MEK, PKC, and CDK4. |
|
DC12316 |
PD-168077 maleate
Featured
|
PD-168077 maleate is a selective dopamine D4 receptor agonist, with a Ki of 9 nM. |
|
DC9258 |
PD168393
Featured
|
PD168393 is potent, cell-permeable, irreversible and selective inhibitor of EGF receptor (EGFR) tyrosine kinase and ErbB2. |
|
DC5095 |
PD169316
Featured
|
PD169316 is a potent and selective p38 MAP kinase inhibitor |
|
DC2054 |
PD-173074
Featured
|
PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM. |
|
DC7571 |
PD173955
Featured
|
PD-173955 is a src tyrosine kinase inhibitor. PD173955 inhibited Bcr-Abl-dependent cell growth. |
|
DC12219 |
PD1-IN-2 |
PD1-IN-2 is a PD1 signaling pathway inhibitor, which acts as an immunomodulator. |
|